AxoGen, Inc.'s VP of Clin. & Trans. Sciences was just granted 10,000 options


Erick Wayne Devinney, AxoGen, Inc.'s VP of Clin. & Trans. Sciences, just received 10,000 options from the company. The strike price of the options received was $2.86, and these expire on May 01, 2021. Devinney now owns at least 25,000 options on the company.

Some additional info was provided as follows:

All shares pursuant to the employee stock option will be fully vested on May 1, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on May 1, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AxoGen, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

AxoGen, Inc. director just picked up 20,000 shares - Aug. 15, 2014

   Auto Refresh

Feedback